Cargando…

High mobility group box-1: a potential therapeutic target for allergic rhinitis

Allergic rhinitis (AR) is a prevalent chronic inflammatory disease of the nasal mucosa primarily characterized by symptoms, such as nasal itching, sneezing, runny nose, and nasal congestion. It has a high recurrence rate and low cure rate, with a lack of effective drugs for treatment. The current ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Shuhua, Yu, Yangyang, Zheng, Zhong, Cheng, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571310/ https://www.ncbi.nlm.nih.gov/pubmed/37828579 http://dx.doi.org/10.1186/s40001-023-01412-z

Ejemplares similares

AIM2 inflammasome activation may mediate high mobility group box 1 release in murine allergic rhinitis
por: Wang, Yan, et al.
Publicado: (2021)

A review of recent advances in exosomes and allergic rhinitis
por: Zheng, Zhong, et al.
Publicado: (2022)

The dual role and therapeutic potential of high-mobility group box 1 in cancer
por: He, Si-Jia, et al.
Publicado: (2017)

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group
por: Richards, Guy A., et al.
Publicado: (2023)

NOVEL THERAPEUTIC APPROACHES FOR ALLERGIC RHINITIS
por: Agosti, Jan M., et al.
Publicado: (2000)

Molecular insights into the multifaceted functions and therapeutic targeting of high mobility group box 1 in metabolic diseases
por: Tao, Zhipeng, et al.
Publicado: (2022)

Allergic rhinitis and association with the O blood group
por: Carpeggiani, Clara
Publicado: (2011)

Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer
por: Takaki, Wataru, et al.
Publicado: (2022)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2011)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2018)

Sex-Determining Region Y Chromosome-Related High-Mobility-Group Box 10 in Cancer: A Potential Therapeutic Target
por: Yu, Liming, et al.
Publicado: (2020)

Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective
por: Wang, Shu, et al.
Publicado: (2022)

Potential significance of high-mobility group protein box 1 in cerebrospinal fluid
por: Wu, Zhiwu, et al.
Publicado: (2023)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
por: DeWulf, Bram, et al.
Publicado: (2023)

IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma
por: Nur Husna, Siti Muhamad, et al.
Publicado: (2022)

Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
por: Fan, Da-Chuan, et al.
Publicado: (2016)

Management of Rhinitis: Allergic and Non-Allergic
por: Tran, Nguyen P, et al.
Publicado: (2011)

High mobility group box-1 protein as a therapeutic target in perinatal hypoxic-ischemic brain injury
por: Hatayama, Kazuki, et al.
Publicado: (2021)

Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review
por: Richard, Seidu A.
Publicado: (2019)

Investigation of Allergic Sensitizations in Children With Allergic Rhinitis and/or Asthma
por: Dai, Lingman, et al.
Publicado: (2022)

Management of allergic rhinitis
por: Solelhac, Geoffroy, et al.
Publicado: (2014)

Acute allergic rhinitis
por: Green, Robin J., et al.
Publicado: (2020)

Probiotics in allergic rhinitis
por: Nogueira, Janaina Cândida Rodrigues, et al.
Publicado: (2015)

Local allergic rhinitis()
por: Mello Junior, João Ferreira de
Publicado: (2016)

Evidence of an association between the O blood group and allergic rhinitis
por: Falsarella, Nelson, et al.
Publicado: (2011)

Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
por: Richard, Seidu A., et al.
Publicado: (2017)

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
por: Che, Yanlu, et al.
Publicado: (2023)

The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
por: Tao, Hong, et al.
Publicado: (2019)

High mobility group box 1 levels as potential predictors of asthma severity
por: Xu, Shuanglan, et al.
Publicado: (2023)

Impact of the Allergic Therapeutic Adherence in Children with Allergic Rhinitis and ADHD: A Pilot Study
por: Gambadauro, Antonella, et al.
Publicado: (2023)

The role of vitamin D in allergic rhinitis
por: Tian, Hui-Qin, et al.
Publicado: (2017)

High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis
por: Goldstein, Richard S
Publicado: (2008)

Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
por: Patel, Mira C., et al.
Publicado: (2018)

Self-assessment of Allergic Rhinitis and Asthma (SACRA) Questionnaire-based Allergic Rhinitis Treatment Improves Asthma Control in Asthmatic Patients with Allergic Rhinitis
por: Yasuo, Masanori, et al.
Publicado: (2017)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage
por: Zhou, Yu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ogs40dksonqh72bgkqr3d1kk3m